![]() Hoffmann-La Roche Ltd, Basel, SwitzerlandĥGenentech, Inc., South San Francisco, CAĦDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, CanadaħMcMaster-Bayer Endowed Research Chair in Clinical Epidemiology of Congenital bleeding Disorders, Department of Medicine, McMaster University, Hamilton, Canada ![]() Sima, MD 5 *, Davide Matino 2 * and Alfonso Iorio, MD, PhD 6,7ġDepartment of Medicine, Cumming School of Medicine University of Calgary, Calgary, AB, CanadaĢDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, CanadaģUniversity of Calgary Cumming School of Medicine, Alberta, CanadaĤF. Frank, MD, PhD 1 and Surbhi Sidana, MD 6ġDivision of Blood and Marrow Transplantation, Stanford University, Stanford, CAĢCenter for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CAģDivision of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CAĤDepartment of Pathology, Stanford University, Palo Alto, CAĥDepartment of Pediatrics, Division of Hematology and Oncology, Stanford University, Stanford, CAĦDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CAĪnalysis of Hemophilia a Outcomes and Treatment Patterns Using Real-World Data from the Canadian Hemophilia Bleeding Disorder RegistryĪdrienne Lee, MD 1, Federico Germini, MD, MSc 2 *, Man-Chiu Poon, MD 3, Arun Keepanasseril 2 *, Quazi Ibrahim, MSc 2 *, Aijing Shang, MD, PhD 4 *, Francis Nissen 4 *, Oliver Meier 4 *, Cami S. Rezvani, MD 1, Theresa Latchford, RN 1 *, Crystal L. Johnston, MD 1, Sally Arai, MD, MS 1, Judith A Shizuru, MD, PhD 1, Robert Lowsky, MD, FRCP 1, Everett H Meyer, MD, PhD 1 *, Wen-Kai Weng, MD, PhD 1, Parveen Shiraz, MD 1, Andrew R. Spiegel, MD, FRCPC 1, Lori Muffly, MD, MS 3, James Zehnder, MD 4, Robert S. 1,2,3,10 *ġSouth Texas Diabetes and Obesity Institute, The University of Texas Rio Grande Valley, Brownsville, TXĢDepartment of Human Genetics, School of Medicine, The University of Texas Rio Grande Valley, Brownsville, TXĤResearch, CSL Behring GmbH, Marburg, GermanyĥDivision of Hematology and Oncology, Department of Internal Medicine, School of Medicine, The University of California at Davis, Davis, CAĦImmunogenetics and Transplantation Laboratory, Department of Surgery, School of Medicine, The University of California at San Francisco, San Francisco, CAĨUniversity of Texas Health Science Center, Houston, TXĩResearch, Bio21 Institute, CSL Limited, Melbourne, Australiaġ0Department of Pathology and Laboratory Medicine, VA Valley Coastal Bend Healthcare System, Harlingen, TXīleeding and Thrombosis Are Associated with Endothelial Dysfunction in CAR-T Cell Therapy and Are Increased in Patients Experiencing Neurologic ToxicityĪndrew Johnsrud, MD 1, Juliana Craig, BA 1 *, John H. 1,2 *, Henry Mead, MBA, MPH 7 *, Satish Kumar, Ph.D. ![]() N-Linked Glycans on Therapeutic Factor VIII (FVIII) Proteins Attenuate Immunogenicity Potential: Evidence from Independent HLA-Class-II/FVIII (HLAcII/FVIII) Peptidomes ![]() Mari Thomas 1 *, Nishkantha Arulkumaran 2 *, David Brearley 3 *, Ferras Alwan 4, Deepak Singh 5 *, Michael P Lunn 6 *, Anna Welch 7 *, Samuel Clark 8 *, Eamon Raith 9 *, Ugan Reddy 9 *, Ryan Low 10 *, David Leverett 7 *, Mervyn Singer 11 * and Marie Scully, MD 12ġDepartment of Haematology, University College London Hospitals, Cardiometabolic Program, National Institute for Health Research UCLH/UCL Biomedical Research Centre, London, ENG, United KingdomĢBloomsbury Institute of Intensive Care Medicine, University College London Hospitals, London, GBRģBloomsbury Institute of Intensive Care Medicine, UCLH, London, United KingdomĤDepartment of Haematology, University College London Hospital, London, United KingdomĥSpecial Coagulation Laboratory UCLH-HSL, London, United KingdomĦDepartment of Neurology, University College Hospital, London, London, United KingdomħUniversity College London Hospitals, London, GBRĨIntensive Care Unit, University College London Hospitals, London, GBRĩNational Hospital for Neurology and Neurosurgery, UCLH, London, United Kingdomġ0Department of Haematology, UCLH, London, United Kingdomġ1Bloomsbury Institute of Intensive Care, University College London Hospital, London, GBRġ2Department of Haematology, University College London Hospitals, Cardiometabolic Program, National Institute for Health Research UCLH/UCL Biomedical Research Centre, London, United Kingdom Plasma Exchange for COVID-19 Thrombo-Inflammatory Disease ![]()
0 Comments
Leave a Reply. |